Conduit Pharmaceuticals Inc. (CDT) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.39x
Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting $40.68 Million (capex $39.68 Million plus investments $-998.00K) from operating cash flow of $105.01 Million. Explore Conduit Pharmaceuticals Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.39x
(Capex + Investments) / Operating CF
Total Reinvested
$40.68 Million
Capex + Investments
Operating Cash Flow
$105.01 Million
USD
Capital Expenditures
$39.68 Million
USD
Annual Cash Flow Reinvestment Rate for Conduit Pharmaceuticals Inc. (None–None)
Year-by-year capital reinvestment analysis for Conduit Pharmaceuticals Inc.. For live market cap and broader valuation context, see Conduit Pharmaceuticals Inc. (CDT) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow